Compare Orchid Chemicals with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs FDC LTD. - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD FDC LTD. ORCHID PHARMA LTD/
FDC LTD.
 
P/E (TTM) x -0.5 17.5 - View Chart
P/BV x 0.1 2.4 5.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA LTD   FDC LTD.
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
FDC LTD.
Mar-18
ORCHID PHARMA LTD/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs194319 60.8%   
Low Rs35164 21.3%   
Sales per share (Unadj.) Rs276.561.6 448.5%  
Earnings per share (Unadj.) Rs-79.29.9 -796.2%  
Cash flow per share (Unadj.) Rs-43.512.0 -363.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.973.2 73.7%  
Shares outstanding (eoy) m70.45174.40 40.4%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x0.43.9 10.6%   
Avg P/E ratio x-1.424.3 -6.0%  
P/CF ratio (eoy) x-2.620.2 -13.1%  
Price / Book Value ratio x2.13.3 64.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,06742,118 19.2%   
No. of employees `0002.85.5 50.6%   
Total wages/salary Rs m2,5272,167 116.6%   
Avg. sales/employee Rs Th6,956.11,943.7 357.9%   
Avg. wages/employee Rs Th902.5391.7 230.4%   
Avg. net profit/employee Rs Th-1,993.0313.7 -635.3%   
INCOME DATA
Net Sales Rs m19,47710,751 181.2%  
Other income Rs m407510 79.9%   
Total revenues Rs m19,88411,260 176.6%   
Gross profit Rs m1,1032,267 48.6%  
Depreciation Rs m2,519351 716.9%   
Interest Rs m5,22714 37,334.3%   
Profit before tax Rs m-6,2362,411 -258.6%   
Minority Interest Rs m20-5 -410.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125671 -18.7%   
Profit after tax Rs m-5,5801,735 -321.6%  
Gross profit margin %5.721.1 26.8%  
Effective tax rate %2.027.8 7.2%   
Net profit margin %-28.716.1 -177.5%  
BALANCE SHEET DATA
Current assets Rs m11,0147,213 152.7%   
Current liabilities Rs m32,0602,104 1,524.0%   
Net working cap to sales %-108.147.5 -227.4%  
Current ratio x0.33.4 10.0%  
Inventory Days Days9554 174.1%  
Debtors Days Days3428 121.0%  
Net fixed assets Rs m29,4406,865 428.8%   
Share capital Rs m705175 402.1%   
"Free" reserves Rs m2,04312,586 16.2%   
Net worth Rs m3,80012,761 29.8%   
Long term debt Rs m9,0186 150,298.3%   
Total assets Rs m46,51015,041 309.2%  
Interest coverage x-0.2173.2 -0.1%   
Debt to equity ratio x2.40 504,742.8%  
Sales to assets ratio x0.40.7 58.6%   
Return on assets %-0.811.6 -6.5%  
Return on equity %-146.913.6 -1,080.1%  
Return on capital %-3.719.0 -19.7%  
Exports to sales %37.912.3 306.9%   
Imports to sales %22.60-   
Exports (fob) Rs m7,3781,327 556.0%   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,5131,889 397.8%   
Fx outflow Rs m5,6490-   
Net fx Rs m1,8651,889 98.7%   
CASH FLOW
From Operations Rs m1,6821,498 112.2%  
From Investments Rs m-9,860201 -4,903.2%  
From Financial Activity Rs m6,644-1,694 -392.1%  
Net Cashflow Rs m-1,53510 -14,902.9%  

Share Holding

Indian Promoters % 32.3 68.9 46.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 4.7 97.9%  
FIIs % 3.3 7.5 44.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 19.0 291.1%  
Shareholders   84,811 23,730 357.4%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  ELDER PHARMA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS